Induction and enhancement of platelet aggregation in vitro and in vivo by model polystyrene nanoparticles
Open Access
- 17 July 2014
- journal article
- Published by Taylor & Francis in Nanotoxicology
- Vol. 9 (3) , 356-364
Abstract
Nanoparticles (NPs) may come into contact with circulating blood elements including platelets following inhalation and translocation from the airways to the bloodstream or during proposed medical applications. Studies with model polystyrene latex nanoparticles (PLNPs) have shown that NPs are able to induce platelet aggregation in vitro suggesting a poorly defined potential mechanism of increased cardiovascular risk upon NP exposure. We aimed to provide insight into the mechanisms by which NPs may increase cardiovascular risk by determining the impact of a range of concentrations of PLNPs on platelet activation in vitro and in vivo and identifying the signaling events driving NP-induced aggregation. Model PLNPs of varying nano-size (50 and 100 nm) and surface chemistry [unmodified (uPLNP), amine-modified (aPLNP) and carboxyl-modified (cPLNP)] were therefore examined using in vitro platelet aggregometry and an established mouse model of platelet thromboembolism. Most PLNPs tested induced GPIIb/IIIa-mediated platelet aggregation with potencies that varied with both surface chemistry and nano-size. Aggregation was associated with signaling events, such as granule secretion and release of secondary agonists, indicative of conventional agonist-mediated aggregation. Platelet aggregation was associated with the physical interaction of PLNPs with the platelet membrane or internalization. 50 nm aPLNPs acted through a distinct mechanism involving the physical bridging of adjacent non-activated platelets leading to enhanced agonist-induced aggregation in vitro and in vivo. Our study suggests that should they translocate the pulmonary epithelium, or be introduced into the blood, NPs may increase the risk of platelet-driven events by inducing or enhancing platelet aggregation via mechanisms that are determined by their distinct combination of nano-size and surface chemistry.Keywords
This publication has 26 references indexed in Scilit:
- Size Influences the Effect of Hydrophobic Nanoparticles on Lung Surfactant Model SystemsBiophysical Journal, 2014
- Total Surface Area Concentration Measurements of Nanoparticles in Gases with an Electrical SensorChemie Ingenieur Technik, 2012
- The plasma membrane calcium ATPase modulates calcium homeostasis, intracellular signaling events and function in plateletsJournal of Thrombosis and Haemostasis, 2010
- Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal ResearchPLOS Biology, 2010
- Emerging applications of nanomedicine for the diagnosis and treatment of cardiovascular diseasesTrends in Pharmacological Sciences, 2010
- Nanoparticle-Mediated IgE−Receptor Aggregation and Signaling in RBL Mast CellsJournal of the American Chemical Society, 2009
- Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organsInhalation Toxicology, 2009
- COMBUSTION‐DERIVED NANOPARTICLES: MECHANISMS OF PULMONARY TOXICITYClinical and Experimental Pharmacology and Physiology, 2007
- Combustion-derived nanoparticles: A review of their toxicology following inhalation exposureParticle and Fibre Toxicology, 2005
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962